Synthetic GHRH Analogue with Drug Affinity Complex
Direct-source pricing: Solira works through manufacturing partnerships to reduce reseller markup while maintaining third-party testing, COA verification, and 99%+ HPLC purity standards.
Buy 3 or more units (any mix) and save 5% off — no code needed, applied at checkout. Mix any compounds.
CJC-1295 with DAC (Drug Affinity Complex) is a modified synthetic GHRH analogue bearing a maleimidopropionic acid group that enables covalent binding to serum albumin in research systems, extending its effective half-life. Supplied as lyophilized powder for laboratory research.
Supplied for in vitro research and preclinical investigation only. Independently verified by HPLC and mass spectrometry.
Store sealed, dry, and protected from light.
Long-term storage: -20°C recommended.
Short-term storage: 2-8°C acceptable.
Reconstitution: Use sterile technique with bacteriostatic water.
Post-reconstitution: Stable up to 30 days at 2-8°C.
All handling instructions are intended for laboratory use only.
Every batch of product sold by Solira Lab undergoes independent third-party analytical testing to verify identity and purity.
COA available upon request. Contact us for lot-specific documentation.
This product is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use. All products sold by Solira Lab are for laboratory and research purposes only. Not for human consumption. Not for diagnostic or therapeutic use. Purchaser assumes all responsibility for the legal and proper use of this product.
You must be 21 years of age or older to access this site.
All products offered on this site are intended for Research Use Only (RUO).
They are not intended for human consumption, diagnostic, or therapeutic use
in humans or animals. By proceeding, you acknowledge that you will use
these products solely for research purposes in accordance with all
applicable laws and regulations.
